1 min read

Let’s Talk Medtech & CLEERLY

Picture of Cleerly Cleerly : April 6, 2022

It’s American Heart Month, and Cleerly, a startup that uses artificial intelligence to change the way we diagnose cardiovascular disease is keeping busy.

Dr. James Min, founder and CEO of Cleerly, joins us on this episode of Let’s Talk Medtech for a riveting discussion about cardiovascular disease during American Heart Month.

Dr. James, “Jim” Min, founder and CEO of Cleerly, joins us on this episode of Let's Talk Medtech for a discussion about American Heart Month and the company’s goals over the next few months.

Cleerly’s  technology was born out of research from the Dalio Institute for Cardiovascular Imaging at the New York-Presbyterian Hospital and Weill Cornell Medicine and uses non-invasive coronary (CT) angiography to perform comprehensive coronary artery phenotyping through AI-enabled and FDA-cleared solutions.

This technology is based on millions of annotated lab images used to build more than two dozen algorithms capable of quantifying and characterizing the presence, extent, severity, and type of coronary artery disease and other cardiovascular disorders. Read full article HERE.
Cardiovascular Blind Spots and How Cleerly Is Changing the Game

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

July 9, 2024

In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...

Read More
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

February 15, 2024

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

December 27, 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

Read More

Interview: Debunking Standard Approach to Monitoring Heart Disease

Picture of Cleerly Cleerly : April 6, 2022

Read on to learn more about a recent Health Professional Radio interview, featuring Dr. James “Jim” K. Min.

Read More

Dicardiology: Cleerly Takes Precision Heart Care to the Next Level

Picture of Cleerly Cleerly : February 15, 2022

Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease. Read on to see more from the article by Dicardiology. ...

Read More

Cleerly's AI scans comparable to gold-standard angiography

Picture of Cleerly Cleerly : April 6, 2022

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More